raiders trial

The RAIDERS randomised clinical trial was designed to determine if artificial intelligence (AI)-supported diabetic retinopathy (DR) screening improved referral uptake in Rwanda. The study showed that immediate feedback on referral status based on AI-supported screening was associated with statistically significantly higher referral adherence compared with delayed communications of results from human graders. These results provide evidence for an important benefit of AI screening in promoting adherence to prescribed treatment for diabetic eye care in sub-Saharan Africa.

Further work on AI explored the real life implementation of screening for DR using AI  providing evidence for its feasibility and acceptability even in a low resource country like Rwanda

Scroll to Top